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The adrenal steroid dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) are two of
the most abundant hormones in the human circulation. Furthermore, they are released in
a circadian pattern and show a marked age-associated decline. Adult levels of DHEA and
DHEAS are significantly higher in males than in females, but the reason for this sexual
dimorphism is unclear. In the present study, we administered supplementary androgens
[DHEA, testosterone and 5α-dihydrotestosterone (DHT)] to aged male rhesus macaques
(Macaca mulatta). While this paradigm increased circulating DHEAS immediately after
DHEA administration, an increase was also observed following either testosterone or DHT
administration, resulting in hormonal profiles resembling levels observed in young males in
terms of both amplitude and circadian pattern.This stimulatory effect was limited to DHEAS,
as an increase in circulating cortisol was not observed.Taken together, these data demon-
strate an influence of the hypothalamo-pituitary–testicular axis on adrenal function in males,
possibly by sensitizing the zona reticularis to the stimulating action of adrenocorticopic hor-
mone.This represents a plausible mechanism to explain sex differences in circulating DHEA
and DHEAS levels, and may have important implications in the development of hormone
therapies designed for elderly men and women.
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INTRODUCTION
Levels of the adrenal steroid dehydroepiandrosterone (DHEA)
and its sulfate (DHEAS; collectively referred to as DHEA/S) dif-
fer between males and females, yet the underlying cause for this
sexual dimorphism is unknown (1). It is clear, however, that
the gross, cellular, and molecular adrenal structure of males and
females is essentially similar, suggesting that some factor out-
side the adrenal gland is responsible for the greater secretion of
DHEA/S in males (2). Given that the sex differences in DHEA/S
are most pronounced during early adulthood, it is plausible that
the different levels of sex-steroid hormones between adult males
and females may play a contributing role. In fact, previous work in
perimenopausal women and macaque models of menopause has
shown that decreasing levels of estrogens correspond to increases
in DHEAS (3–5), and estrogen replacement paradigms decrease
DHEA/S (5, 6) at a rate greater than seen in normal aging without
estrogen supplementation. As DHEA/S is a precursor to estra-
diol (7), this may reflect a compensatory interaction between
the hypothalamic–pituitary–gonadal (HPG) and hypothalamic–
pituitary–adrenal axes. On the other hand, males have higher
circulating levels of DHEAS than do females, despite having sub-
stantially higher levels of testosterone (T). This suggests that an
inverse relationship between adrenal and gonadal steroids exists in
females, whereas a positive causal relationship may exist in males.
The hormone systems discussed so far not only have the
potential for interacting with each other, but they also show
significant age effects. In both sexes, DHEA/S declines gradually
and consistently starting in early adulthood, with levels reaching
roughly 40% of their peak by the middle age and continuing to
decline thereafter (8, 9). In females, menopause is associated with
a sudden decline in estrogen (10, 11), while males show a less
precipitous decline in testosterone during aging. The situation is
further complicated by therapeutic hormonal supplementation in
the elderly, which can alter circulating sex-steroid hormone levels,
though not necessarily in the most appropriate physiological man-
ner. Furthermore, in the USA DHEA is sold as a food supplement,
requiring no prescription, and so is widely used by the elderly
for self-medication. Thus, to fully understand the physiological
impact of hormone changes with age the interactions between
the HPG and HPA axes require further investigation under care-
fully controlled experimental conditions, something that can be
achieved more readily using non-human primates such as the
rhesus macaque.
Physiological replacement of steroids may protect against many
negative aspects of aging, but it is first important to understand
the differences between males and females and how these systems
interact to determine the safest and most effect form of hormone
therapy (HT). We used the rhesus macaque, a large diurnal pri-
mate with endocrine physiology very similar to that of humans,
to investigate the interactions between DHEA/S and testosterone.
Because we recently observed novel interactions in a combined
androgen supplementation paradigm (12, 13), we have expanded
on this previous research to formulate a working hypothesis for
adrenal and gonadal interactions. Our results indicate a strong
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influence of testosterone on circulating levels of DHEAS, possibly
explaining the drastic differences between male and female levels
of the hormone.
MATERIALS AND METHODS
ANIMALS
The study used adult rhesus macaques (Macaca mulatta), and
was approved by the OHSU Institutional Animal Care and Use
Committee. The animals were cared for by the Division of Com-
parative Medicine at the Oregon National Primate Research Center
(ONPRC) in accordance with the National Research Council’s
Guide for the Care and Use of Laboratory Animals. They were
caged singly indoors under controlled environmental conditions:
24°C temperature; 12-h light, 12-h dark photoperiods (lights on
at 0700 h). Monkey chow was provided at 0800 and 1500 h and
was supplemented with fresh fruit and vegetables; fresh drinking
water was available ad libitum.
In Experiment 1, ten adult (11–12 years) male and eight adult
(11–12 years) female rhesus macaques were used to assess sex dif-
ferences in circulating DHEAS levels. In Experiment 2, four young
adult (7–12 years) and four old (21–26 years) males were used
to examine age-related changes in circulating DHEAS levels; five
additional old males were used to evaluate the impact of androgen
supplementation on DHEAS.
REMOTE BLOOD SAMPLING
Cortisol and DHEA/S both demonstrate a circadian pattern of
release (14–16). Therefore, to gain meaningful insights regarding
sex-related or age-related hormone differences it was necessary to
collect blood samples from each animal serially across an entire
24-h period. To achieve this with minimal disruption of the ani-
mals, each monkey was surgically implanted with a subclavian vein
catheter, leading to a remote blood sampling system in an adjacent
room, as previously described (17). Blood samples were collected
into EDTA-coated borosilicate glass tubes every hour for a com-
plete 24-h cycle. The samples were centrifuged at 4°C, and the
plasma was stored at −20°C until assay for cortisol and DHEAS.
Cortisol was assayed using electrochemiluminescence using the
Elecsys 2010 Platform (Roche Diagnostics, Indianapolis, IN, USA).
DHEAS was assayed using radioimmunoassay with a highly
specific antibody for DHEAS-17-(O-carboxymethyl)oxime-BSA
(Endocrine Services, Tarzana, CA, USA) and [3H]DHEAS (SA,
22 Ci/mmol). Intra- and interassay coefficients of variation were
less than 10% for each assay and the assay detection limits were
3 ng/ml. The 24-h serial blood sampling procedure was performed
once on each animal, except for the old androgen-supplemented
animals, which were re-sampled after each of the 5-day androgen
supplementation tests, performed approximately 1 month apart
(Table 1). Data were analyzed using a repeated-measures ANOVA
with time as a within-subjects factor and group (young, old
baseline, old supplemented) as a between-subjects factor. When
the assumption of sphericity was not met, a Greenhouse-Geisser
correction was implemented.
STEROID SUPPLEMENTATION
Animals were treated with hormones for 5 days prior to each
blood sampling session to allow steroid levels to equilibrate.
Table 1 | Steroid supplementation paradigms.
Time of hormone administration
Experiment 0700 h 1000 h 1900 h
Baseline – – –
1 DHEA (0.04 mg/kg) DHEA (0.04 mg/kg) T (12 mg/kg)
2 DHEA (0.10 mg/kg) DHEA (0.05 mg/kg) –
3 DHEA (0.10 mg/kg) DHEA (0.05 mg/kg) DHT (5–10 mg/kg)
4 T (12 mg/kg) – –
The times and doses of the four androgen supplementation paradigms are shown.
Due to limitations on blood sampling, not all combinations of hormones were
able to be tested at all doses. DHEA and T were dissolved in sesame oil, and
were mixed into chocolates for oral supplementation. Animals were monitored
to ensure the entire dose was eaten in a timely manner.
DHEA (10 mg/ml; Sigma-Aldrich, St. Louis, MO, USA), testos-
terone (T, 120 mg/ml; Sigma-Aldrich), and dihydrotestosterone
(DHT, 5–10 mg/ml; Sigma-Aldrich) were dissolved in commercial
food-grade sesame oil and mixed with melted chocolate, a pre-
ferred treat. The steroids were dissolved in sesame oil to reduce
their uptake and rapid metabolism by the liver and instead by
increasing their absorption through the lymphatic system (18,
19). Chocolates were kept refrigerated at 4°C until the time of
administration. Animals were watched at the time of adminis-
tration to ensure the entire treat was eaten. To isolate potential
mechanisms of adrenal androgen interaction, four supplementa-
tion paradigms were performed (Table 1): (1) DHEA administered
at 0700 and 1000 h, T administered at 1900 h; (2) DHEA admin-
istered at 0700 and 1000 h; (3) DHEA administered at 0700 and
1000 h, DHT administered at 1900 h; and (4) T administered at
0700 h. These doses were selected based on preliminary experi-
ments that were aimed at replicating the hormone levels observed
in young adults; consequently, the doses varied between experi-
ments. To protect animals against excessive blood sampling, it was
not feasible to repeat all hormone combinations at all doses in all
of the animals. Times were chosen to replicate the endogenous cir-
cadian peaks of T and DHEA, while in the last experiment T was
administered in the morning to examine a possible role of time of
day on the steroid response to T. Animals were monitored at the
time of steroid supplementation to ensure each ate the entire treat
in a timely manner; if the treat was refused, an equivalent dose
was administered via a steroid-soaked cookie or prune. The doses
used for each experiment are provided in the respective figures. As
shown previously (13), the dose paradigm used in Experiment 1 is
sufficient to restore circulating T and DHT to levels seen in young
adult male rhesus macaques.
RESULTS
YOUNG ADULT MALE RHESUS MACAQUES SHOW SIGNIFICANTLY
HIGHER LEVELS OF DHEAS THAN FEMALES
Cortisol and DHEAS showed well-defined 24-h plasma profiles,
both in the males and females (Figures 1A,B, respectively). The
plasma levels rose gradually during the night and reached a peak in
the morning at about the time when the lights came on. Although
mean cortisol levels were similar in the two sexes, mean DHEAS
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FIGURE 1 |Twenty-four-hour plasma profiles of adrenal steroids in
male and female rhesus macaques. Serial blood samples were remotely
collected from adult (11–12 years) male (n=10) and female (n=8) animals
and assayed for cortisol (A) and DHEAS (B). Each data point represents the
mean and vertical lines indicate the SEM. Time of day is indicated along the
abscissa, and periods of darkness and light are represented by black and
white bars, respectively. In both sexes, cortisol and DHEAS levels rose
gradually during the night and reached peak levels around the time of lights
on in the morning. Mean cortisol levels were similar in the two sexes,
whereas mean DHEAS levels were significantly higher in males than in
females (P <0.01, Student’s t -test.)
levels were significantly higher in males than in females (P < 0.01,
Student’s t -test).
AGING IS ASSOCIATEDWITH DECREASED CIRCULATING DHEAS LEVELS
As shown in Figure 2A, circulating levels of DHEAS at baseline
were significantly lower in aged (open squares) than in young
males (open circles). A repeated-measures ANOVA with time
as within-subjects factor and group (young and old base-
line) as between-subjects factor indicated a significant effect
of time (F = 6.427, P < 0.001), significant effect of group
(F = 21.828, P = 0.003), and a significant group-by-time inter-
action (F = 7.146, P = 0.001). Circulating DHEAS was higher in
young males at all time points.
TESTOSTERONE ADMINISTRATION IN AGED MALE RHESUS
MACAQUES SIGNIFICANTLY INCREASES CIRCULATING DHEAS TO
LEVELS OBSERVED IN YOUNG MALE RHESUS MACAQUES
Supplementation with DHEA resulted in a significant increase
in circulating DHEAS in old males shortly after administration
(Figure 2A, closed circles). Interestingly, although DHEAS lev-
els declined throughout the day, they again began to increase
shortly after administration of T at 1900 h. This increase was sus-
tained throughout the night, resulting in higher DHEAS levels than
baseline in the morning before DHEAS had been administered.
The supplementation paradigm was modified to further
explore this phenomenon. If DHEAS rose throughout the night
in the absence of exogenous T, we could conclude that this is a
possible priming effect, by which exogenous DHEA stimulates the
adrenal glands to produce more of their own DHEAS for the fol-
lowing day. However, as shown in Figure 2B, circulating DHEAS
remained low throughout the night when no T was admin-
istered. A repeated-measures ANOVA with Greenhouse-Geisser
correction for differences in sphericity was performed, compar-
ing DHEAS between 1900 and 0700 h in animals receiving both
T and DHEA as described versus animals receiving DHEA in the
morning but no T at 1900 h. This test revealed a significant effect
of time (F = 4.978,P = 0.026), treatment (F = 20.786,P = 0.003),
and treatment-by-time interaction (F = 10.640, P = 0.002).
DHT ADMINISTRATION IN AGED MALE RHESUS MACAQUES
SIGNIFICANTLY INCREASES CIRCULATING DHEAS TO LEVELS SEEN IN
YOUNG MALE RHESUS MACAQUES
The results from the previous experiments suggest that T itself
can increase circulating DHEAS. Testosterone is only two steps
beyond DHEA in the steroidogenic pathway, and our dose of T
needed to be very high in order to increase circulating levels to
those of young animals. Therefore, we hypothesized that some of
the exogenous T may have been back-converted to DHEAS, result-
ing in the observed gradual increase in circulating DHEAS levels.
To test this possibility we replaced the exogenous T in our andro-
gen supplementation paradigm with its more active metabolite,
DHT. We reasoned that if our administered T was being converted
back to DHEAS, then substitution of T with DHT, a hormone fur-
ther along the steroidogenic pathway, should prevent the increase
in DHEAS levels from occurring. However, the results clearly
show that even with this alternate androgen supplementation par-
adigm circulating DHEAS increased above baseline levels starting
at 1900 h; the resulting hormone pattern was nearly identical to
that of young control animals (Figure 2C). A repeated-measures
ANOVA between the baseline and DHT-supplemented animals
revealed a significant effect of group (F = 12.944,P = 0.009), with
DHT treatment resulting in an increase in circulating DHT start-
ing at 1900 h. These data suggest that not only is a back-conversion
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FIGURE 2 | Age-related changes in circulating adrenal steroid levels
in male rhesus macaques, and the impact of androgen
supplementation. Serial blood samples were remotely collected from
young (7–12 years, n=4) and old (21–26 years, n=4) males, as well as
old males exposed to 5 days of various androgen supplementation
paradigms (21–26 years, n=5). The samples were subsequently assayed
for DHEAS (A–C) and/or cortisol (D). Each data point represents the
mean and vertical lines indicate the SEM. Time of day is indicated along
the abscissa, and periods of light and darkness are represented by white
and black bars, respectively. In each panel, the times of oral androgen
administration are depicted as follows: D=DHEA (0.04–0.10 mg/kg body
weight), T= testosterone (12 mg/kg body weight), DHT=5α-DHT
(5–10 mg/kg body weight). For reference, the same DHEAS profiles from
the young and old controls are depicted in (B–C). The data demonstrate
that androgen supplementation at an appropriate time of day can restore
24-h circulating DHEAS levels in old males rhesus macaques.
Importantly, they also demonstrate an unexpected stimulatory action of
gonadal steroids on DHEAS.
of T to DHEA/S unlikely, but that the increase in circulating
DHEAS is an androgen-receptor-mediated mechanism.
TESTOSTERONE AND DHEA SUPPLEMENTATION DO NOT CAUSE AN
INCREASE CIRCULATING CORTISOL
Both DHEA and cortisol are secreted by the adrenal gland in
response to adrenocorticotropic hormone (ACTH) from the hypo-
thalamus. To further examine where testosterone is having an
effect to increase DHEAS, we also assayed a series of 24 h blood
samples from our DHEA and T combined supplementation par-
adigm for cortisol. If androgen activation at the level of the brain
increases ACTH secretion, cortisol would also increase at the time
of T supplementation. However, as shown in Figure 2D, T supple-
mentation did not result in increased circulating cortisol levels. A
repeated-measures ANOVA with time as a within-subjects factor
and group (old control, open circles; old androgen-treated, closed
circles; and young, open squares) as a between subjects factor
revealed a significant effect of time (F = 56.758,P < 0.001), group
(F = 5.438,P = 0.028), and group-by-time interaction (F = 2.093,
P < 0.001). The significant effect of group was driven by differ-
ences between the old control and old androgen-treated animals,
with androgen treatment associated with significant reductions
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in circulating cortisol at 1000, 1500, 2100, 2200, 2300, 2400, and
0300 h. There was no significant difference between circulating
cortisol in the young animals as compared to either the old control
or old androgen-treated animals.
DISCUSSION
Research on adrenal sex differences in humans and non-human
primates is limited, but some interesting observations have been
made. The finding that DHEA/S differs dramatically between
males and females is highly consistent and is maintained through-
out the lifespan in both humans and rhesus macaques (7, 20–22),
but to date no theories as to the mechanism of this difference have
been adequately investigated. The differences in aging profiles of
adrenal and gonadal hormones further complicates any potential
interactions, as estrogen in females drops precipitously at the time
of menopause, DHEA/S in both sexes declines slowly and consis-
tently starting in the third decade (8), and testosterone in males
decreases very slowly, gradually, and to a much lesser extent than
other hormones (23–25).
While much work is yet to be done to study differences between
the male and female adrenal gland, early work suggests that the
difference in adrenal output is not due to intrinsic physiolog-
ical differences but due to differential hormonal input to the
adrenal glands of males and females. Although sex differences in
both circulating DHEA/S and adrenal morphology and physiol-
ogy are seen in the marmoset, with respect to both size of the
zona reticularis (ZR, the layer of the adrenal gland that synthesizes
DHEA/S) and expression of steroidogenic genes, similar differ-
ences are not observed in humans. Specifically, in the marmoset,
females secrete significantly more DHEA/S than males due to both
gross anatomical differences in the adrenal gland with increased
adrenal zonation, as well as differences in enzymatic machinery
with an increased expression of cytochrome b5 (26). However,
in humans the male and female ZR are similar in both size and
cytochrome b5 expression (27). Also, cultured male and female
adrenal glands respond with identical levels of DHEA secretion
when stimulated by ACTH (2). Further, females receiving long-
term treatment with T show an increased response of DHEA
to ACTH stimulation as compared to female controls (28, 29),
suggesting that the adrenal machinery is the same in males and
females, but the hormonal input from the HPG axis can modu-
late adrenal output. Given the established research on male and
female adrenal physiology and the lack of evidence for sex differ-
ences in either gross morphology or cellular physiology, it is our
hypothesis that the higher level of DHEAS seen in male humans
and non-human primates is due to T increasing the sensitivity of
the ZR to ACTH. Consistent with this hypothesis, our paradigm
of testosterone supplementation significantly increased circulat-
ing DHEAS of aged male macaques in a manner mimicking the
circadian profile of DHEAS in young male macaques.
Although we cannot rule out the possibility that our androgen
supplementation paradigms acted further up in the hypothalamo-
pituitary–adrenal axis, it is unlikely that CRH or ACTH were
affected because we saw no stimulatory effect of androgen on
cortisol; like DHEA/S, cortisol is stimulated by ACTH but is
secreted primarily from the zona fasicularis (ZF) rather than the
ZR. Also, several studies suggest ACTH secretion is similar in
males and females (30–33). Previous studies of post-menopausal
women found that long-term administration of DHEA increased
DHEA production in response to ACTH (34, 35), a finding we
did not replicate presently as when DHEA was administered
without testosterone we observed no night-time increase in cir-
culating DHEAS. However, our study supplemented animals for
less than 1 week, which may not have been enough time to ade-
quately increase adrenal sensitivity to ACTH. Thus, it is likely that
increased levels of both DHEA/S and T can induce the adrenal
glands to produce more DHEA/S.
One endogenous disturbance of normal androgen interactions
can be seen in the case of polycystic ovarian syndrome (PCOS),
in which women exhibit high levels of both testosterone and
DHEA/S, and these women demonstrate an increased responsive-
ness of DHEAS production when stimulated with ACTH (36).
High levels of testosterone have in fact been implicated as a poten-
tial cause of PCOS (37, 38); however, the impact of increased
testosterone on circulating DHEA/S in women has yet to be studied
extensively.
One of the most common complaints in aging is a decline in
cognition (39, 40), a domain that has been studied extensively
with regard to estrogens, T, and DHEA/S. While some success has
been seen with estrogen replacement in younger women post-
ovohysterectomy (41), and with testosterone supplementation in
elderly men (42–44), results from large-scale HT studies are bleak
at best (45, 46). Despite promising results in rodents and benefits
of the HT on other target tissues, such as maintenance of muscle
mass (47), bone density (48, 49), and immune function (50, 51),
DHEA/S supplementation in elderly humans (52–56) shows lit-
tle to no effect on cognition. A potential drawback of all of these
studies is their focus on just one component of the endocrine sys-
tem. As these hormones interact, changing one steroid may result
in compensation by others, rendering the effects null. Therefore, a
combination of adrenal and gonadal HT may be more promising
for the cognitive domain than HT with any one steroid alone.
Our results indicate that not only does the interaction between
DHEAS and T occur in the adrenal gland (and not the hypothal-
amus, as higher ACTH would increase circulating cortisol), but it
is limited to an effect on the ZR, the area that produces DHEA/S,
and not the ZF, the area that synthesizes cortisol, as cortisol levels
were not affected by T administration. Additionally, DHEAS, but
not cortisol, decreased with age, suggesting changes in only the
ZR occur with age. This is consistent with studies showing regres-
sion of the ZR in older humans (27, 57) and rhesus macaques (5).
However, the ability of the adrenal gland to respond to T admin-
istration with youthful production of DHEAS suggests DHEA/S
production itself is not impaired with age, but the responsive-
ness of the ZR to ACTH may be dampened. Thus, it may not be
necessary to supplement with DHEA itself to increase circulating
DHEAS levels in the elderly; merely supplementing with T with the
physiologically correct time course may help to restore an overall
youthful hormonal profile in elderly men.
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